How Are Vaccines Deemed Safe?
A discussion on the process by which the FDA regulates vaccine candidates at a time when COVID-19 candidates are progressing.
Watch
Coronavirus Science Is Not Binary
Why reducing pandemic research and response to yes-or-no outcomes is harming public health.
Connecting COVID-19 to Cancer Research
Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.
Setting Standards for a COVID-19 Vaccine
What should be anticipated in effectiveness and implication for the leading candidates.
Ebola Survivors Face Stigma, Reproductive Health Impact
Infectious disease specialists explain how long term international cooperation with impacted societies can help to stop the cycle of Ebola outbreaks.
Can We Fight Coronavirus Without a Vaccine? Explaining Monoclonal Antibody Research
What happens if we don't get a COVID-19 vaccine? Patrick Soon-Shiong, MD, describes another potential route for research efforts, which could also supplement vaccine development.
More Than Respiratory: Looking at How COVID-19 Affects Other Systems
One cardiologist speaks about what she witnessed in her NYC hospital including how the virus can be multi-organ and the development of COVID-19 diagnostic protocols.
Can Moderna's COVID 19 Vaccine Generate Lasting Immunity?
Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.
Contagion Rapid Readout: A Clinical Review of Remdesivir for COVID-19
A discussion between providers on 3 studies related to the antiviral.
Interpreting the Oxford, Moderna COVID-19 Vaccine Data
Angela Rasmussen, PhD, explains how preliminary findings for both candidates define their potential for preventing or lessening coronavirus.
A World Without Antibiotics? Why Patients Should Care About Resistance
Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.
The Stakes of Antibiotic Stewardship
Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.
Providers: Face Masks Outside Hospital Settings, Counseling Patients on COVID-19
In this second installment of his interview, Howard Koh, MD, MPH, discusses the importance of providers and health care workers wearing face masks during their interactions with patients.
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
Calling Upon Florida and the Nation to Require Face Masks
A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
A Timeline to Heparin in COVID-19 Patients
Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.
Could Heparin Prevent Coronavirus Infection?
A discussion with an RPI investigator after promising early findings.
COVID-19 Pandemic Threatens Global Infectious Disease Control Progress
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
Applying African Ebola Response Experience to the Coronavirus Pandemic
West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.
The Dangers of Respiratory Droplets to Frontline Health Care Providers
A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.
How Will Coronavirus Impact HIV, TB, & Malaria in Developing African Countries?
A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.
Who Should be Wearing Face Masks?
Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.
Why is Ebola Endemic to the DRC?
In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.
Getting Younger People on PrEP
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
Complicating the Coronavirus Lockdown Debate
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
Unmet HIV Therapy Needs, Cure Research, and Virtual Conferences
In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.
The Social Hurdles of HIV Awareness and Prevention
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
Insights into Vesatolimod
Gilead provides some important information on this investigational therapy.